API Manufacturing vs. API Development: What Is the Difference?
A sponsor requesting an API batch may receive a proposal that includes route optimisation, analytical work and process studies. Why is development needed when the molecule has already been synthesised?
The answer lies in the difference between knowing that a compound can be made and knowing how to produce it consistently for a defined purpose. API development and API manufacturing address connected, but distinct, needs.
Development establishes how the material should be made
API development services investigate the process used to prepare an active pharmaceutical ingredient. For small molecules, this may include route selection, reaction optimisation, impurity understanding, isolation and solid-form studies.
The work asks questions such as: Which route is practical? What causes the main impurity? How sensitive is the reaction to temperature? Can the product be isolated without repeated chromatography?
Development also establishes analytical understanding. Teams need methods capable of assessing relevant quality attributes and detecting changes as the process evolves.
The deliverables therefore extend beyond material. They may include experimental reports, process descriptions, analytical methods and an explanation of known risks.
Manufacturing executes a defined process
API manufacturing produces material using an established process under the quality arrangements appropriate to its intended use. It involves production planning, raw-material control, equipment preparation, batch execution, testing and review.
The central question becomes: Can this batch be produced and released in accordance with the agreed process and requirements?
For example, a production team may manufacture a clinical API batch using a process developed earlier. The team follows approved instructions, records operations, monitors defined parameters and investigates unexpected events through the applicable quality system.
The API remains the drug substance. Producing it does not, by itself, mean that a finished tablet, capsule or injectable has also been manufactured.
The boundary is not a single handover date
Development and manufacturing overlap throughout a programme. An early manufacturing campaign may reveal a filtration problem that requires further investigation. A later increase in demand may justify changing an inefficient step.
A development-stage process may also be adequate for an immediate clinical requirement without being the final commercial process. Decisions should reflect the programme stage, available knowledge and quality expectations.
This is why an apparently simple request for more material can create development work. Moving from a small laboratory vessel to production equipment may expose differences in mixing, heat transfer or isolation.
Match the proposal to the actual need
A sponsor with only a discovery route may need significant process and analytical development before manufacture. A sponsor transferring an established process may need a different package focused on transfer, facility fit and production readiness.
When reviewing API manufacturing services, clarify which activities are included. Who will supply reference standards? Are methods already transferable? What studies are needed before the proposed scale? Who reviews changes and release documentation?
These questions prevent a low manufacturing quotation from being mistaken for the full cost of reaching a usable batch.
Plan development and supply together
Jubilant Biosys offers capabilities relevant to both API development and manufacture. Sponsors should define the starting knowledge and the intended material use before agreeing the scope.
API development establishes and improves the process. API manufacturing puts that process into operation. A realistic programme connects the two, preserving the scientific knowledge needed to explain how the material was made and why its quality can be trusted.
Editorial reference (not part of submission)
https://www.jubilantbiosys.com/services/api-manufacturing/API Manufacturing vs. API Development: What Is the Difference?
A sponsor requesting an API batch may receive a proposal that includes route optimisation, analytical work and process studies. Why is development needed when the molecule has already been synthesised?
The answer lies in the difference between knowing that a compound can be made and knowing how to produce it consistently for a defined purpose. API development and API manufacturing address connected, but distinct, needs.
Development establishes how the material should be made
API development services investigate the process used to prepare an active pharmaceutical ingredient. For small molecules, this may include route selection, reaction optimisation, impurity understanding, isolation and solid-form studies.
The work asks questions such as: Which route is practical? What causes the main impurity? How sensitive is the reaction to temperature? Can the product be isolated without repeated chromatography?
Development also establishes analytical understanding. Teams need methods capable of assessing relevant quality attributes and detecting changes as the process evolves.
The deliverables therefore extend beyond material. They may include experimental reports, process descriptions, analytical methods and an explanation of known risks.
Manufacturing executes a defined process
API manufacturing produces material using an established process under the quality arrangements appropriate to its intended use. It involves production planning, raw-material control, equipment preparation, batch execution, testing and review.
The central question becomes: Can this batch be produced and released in accordance with the agreed process and requirements?
For example, a production team may manufacture a clinical API batch using a process developed earlier. The team follows approved instructions, records operations, monitors defined parameters and investigates unexpected events through the applicable quality system.
The API remains the drug substance. Producing it does not, by itself, mean that a finished tablet, capsule or injectable has also been manufactured.
The boundary is not a single handover date
Development and manufacturing overlap throughout a programme. An early manufacturing campaign may reveal a filtration problem that requires further investigation. A later increase in demand may justify changing an inefficient step.
A development-stage process may also be adequate for an immediate clinical requirement without being the final commercial process. Decisions should reflect the programme stage, available knowledge and quality expectations.
This is why an apparently simple request for more material can create development work. Moving from a small laboratory vessel to production equipment may expose differences in mixing, heat transfer or isolation.
Match the proposal to the actual need
A sponsor with only a discovery route may need significant process and analytical development before manufacture. A sponsor transferring an established process may need a different package focused on transfer, facility fit and production readiness.
When reviewing API manufacturing services, clarify which activities are included. Who will supply reference standards? Are methods already transferable? What studies are needed before the proposed scale? Who reviews changes and release documentation?
These questions prevent a low manufacturing quotation from being mistaken for the full cost of reaching a usable batch.
Plan development and supply together
Jubilant Biosys offers capabilities relevant to both API development and manufacture. Sponsors should define the starting knowledge and the intended material use before agreeing the scope.
API development establishes and improves the process. API manufacturing puts that process into operation. A realistic programme connects the two, preserving the scientific knowledge needed to explain how the material was made and why its quality can be trusted.
Editorial reference (not part of submission)
https://www.jubilantbiosys.com/services/api-manufacturing/
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek